Publication: 3427

Publication: 3427

Pharmacogenetic Study in Gastric Cancer Patients Treated with Adjuvant Fluorouracil/Leucovorin or Epirubicin/Cisplatin/Fluorouracil Before and After Chemoradiation on CALGB 80101 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Pharmacogenet Genomics vol 31 (9) 215-220

Year:: 2021
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 11

Parents:: 2269
Children:: None

Program:: TRP
Primary Committee:: PPP
Sec. Committees:: GI

Pharmas:
Grants:: U10 CA180821, U10 CA180882, U24 CA196171, U01GM61390, U01GM61393, U01GM63440; U10CA031983, U10CA060138, UG1CA233160, UG1CA233180, UG1CA233253, UG1CA233327, UG1CA233337, UG1CA233373, U10CA180857; U10CA180863 (CCTG); U10CA180868 (NRG Oncology/RTOG); U10CA180820 (ECOG-ACRIN); and U10CA180888 (SWOG)

Corr. Author:
Authors:: Jai N. Patel Chen Jiang Kouros Owzar Flora Mulkey Jasmine A. Luzum Harvey J. Mamon Daniel G. Haller Tomislav Dragovich Steven R. Alberts Georg Bjarnason Christopher G. Willet Donna Niedzwiecki Peter Enzinger Mark J. Ratain Charles Fuchs Howard L. McLeod

Networks:: FL003, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC010, NC002

Study: CALGB-80101
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: pharmacogenetic, gastric, cancer, polymorphism, gene, toxicity